Status:

COMPLETED

Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation

Lead Sponsor:

Instituto Valenciano de Infertilidad, IVI VALENCIA

Conditions:

Infertility

Eligibility:

FEMALE

18-44 years

Phase:

PHASE4

Brief Summary

Oocyte donation is a well established procedure in assisted reproduction treatments (ART). It is demonstrated that the use of hormonal substitution therapy, for the synchronization of the cycles betwe...

Eligibility Criteria

Inclusion

  • infertile females with preserved gonadal function
  • ages 18 - 43 years old

Exclusion

  • BMI: \> 28
  • recurrent miscarriages
  • severe male factor
  • important miomas
  • \> 44 years old

Key Trial Info

Start Date :

January 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2009

Estimated Enrollment :

570 Patients enrolled

Trial Details

Trial ID

NCT00633347

Start Date

January 1 2007

End Date

October 1 2009

Last Update

February 15 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IVI Valencia

Valencia, Spain, 46015

Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation | DecenTrialz